Innovations at a Glance
-
Conducting pioneering work in high-intensity focused ultrasound, which heats and destroys target lesions to eliminate or greatly diminish essential tremor
-
Investigators in the largest study of a single institution comparing concussion rates in collegiate athletes, which found that female athletes were more likely than male athletes to experience concussion
-
Among the country’s foremost experts advancing the application of deep brain stimulation, including the use of diffusion tensor imaging to guide targeting in the OR, to treat symptoms of Parkinson’s disease
-
Established multidisciplinary brain metastases programs that provide patients with the latest diagnostic and treatment modalities to help address the consequences of metastases and side effects of therapy
-
Advancing the use of middle meningeal arterial embolization to treat subdural hematoma, a groundbreaking minimally invasive approach that can spare patients from the risks of open surgery
-
One of 28 clinical sites across the country for NeuroNEXT, an NIH-Network for Excellence in Neuroscience Clinical Trials created to expand capabilities for studies of promising new therapies for neurological diseases
-
National leaders in the use of MRI-guided laser interstitial thermal ablation therapy for patients with medically intractable focal epilepsy
-
Certified by The Joint Commission and the American Heart Association/American Stroke Association as a Comprehensive Stroke Center, recognizing the long-term experience and highly specialized expertise of NewYork-Presbyterian’s stroke teams
-
Launched the first Mobile Stroke Treatment Unit on the East Coast, bringing specially trained paramedics, a CT technologist, and a neurologist who can administer tPA in the ambulance saving upwards of 30 minutes in time to treatment
